CoChat

Intraarticular injection of bone marrow‐derived mesenchymal stem cells enhances regeneration in knee osteoarthritis

Open access
Doyle, Emily Claire, Wragg, Nicholas Martin, Wilson, Samantha Louise · 2020 · Knee Surgery, Sports Traumatology, Arthroscopy
Cited by 102

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Purpose: This review aimed to evaluate the efficacy of intra‐articular injections of bone marrow derived mesenchymal stem cells (BM‐MSCs) for the treatment of knee osteoarthritis (KOA). Methods: This narrative review evaluates recent English language clinical data and published research articles between 2014 and 2019. Key word search strings of (((“bone marrow‐derived mesenchymal stem cell” OR “bone marrow mesenchymal stromal cell” OR “bone marrow stromal cell”)) AND (“osteoarthritis” OR “knee osteoarthritis”)) AND (“human” OR “clinical”))) AND “intra‐articular injection” were used to identify relevant articles using PMC, Cochrane Library, Web Of Science and Scopus databases. Results: Pre‐clinical studies have demonstrated successful, safe and encouraging results for articular cartilage repair and regeneration. This is concluded to be due to the multilineage differential potential, immunosuppressive and self‐renewal capabilities of BM‐MSCs, which have shown to augment pain and improve functional outcomes. Subsequently, clinical applications of intra‐articular injections of BM‐MSCs are steadily increasing, with most studies demonstrating a decrease in poor cartilage index, improvements in pain, function and Quality of Life (QoL); with moderate‐to‐high level evidence regarding safety for therapeutic administration. However, low confidence in clinical efficacy remains due to a plethora of heterogenous methodologies utilised, resulting in challenging study comparisons. A moderate number of cells (40 × 10 6) were identified as most likely to achieve optimal responses in individuals with grade ≥ 2 KOA. Likewise, significant improvements were reported when using lower (24 × 10 6) and higher (100 × 10 6) cell numbers, although adverse effects including persistent pain and swelling were a consequence. Conclusion: Overall, the benefits of intra‐articular injections of BM‐MSCs were deemed to outweigh the adverse effects; thus, this treatment be considered as a future therapy strategy. To realise this, long‐term large‐scale randomised clinical trials are required to enable improved interpretations, to determine the validity of efficacy in future studies. Level of evidence: IV.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00167-020-05859-z

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 102

Metadata

Authors
Doyle, E. C., Wragg, N. M., & Wilson, S. L.
Venue
Knee Surgery, Sports Traumatology, Arthroscopy
Publisher
Wiley
Published
2020-01-31
Volume
28
Issue
12
Pages
3827-3842
ISSN
  • 0942-2056 (ISSN-L)
  • 1433-7347
OpenAlex
W3003291744
Cited by
102
References
3
FWCI
9.69
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intraarticular injection of bone marrow‐derived mesenchymal stem cells enhances regeneration in knee osteoarthritis. https://app.cochat.ai/papers/10.1007/s00167-020-05859-z
The paper
Doyle, E. C., Wragg, N. M., & Wilson, S. L. (2020). Intraarticular injection of bone marrow‐derived mesenchymal stem cells enhances regeneration in knee osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy. https://doi.org/10.1007/s00167-020-05859-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.